LON:SBI Sourcebio International (SBI) Share Price, News & Analysis → Do NOT read if you believe in “woke” politics (From Stansberry Research) (Ad) Free SBI Stock Alerts GBX 115 +5.00 (+4.55%) (As of 12/29/2022) Add Compare Share Share Today's Range 105▼ 12550-Day Range 115▼ 11552-Week Range 90▼ 170Volume1.57 million shsAverage Volume152,444 shsMarket Capitalization£85.31 millionP/E Ratio1,277.78Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sourcebio International alerts: Email Address Ad DTIIs Tesla going out of business?Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. Click here for the full story About Sourcebio International Stock (LON:SBI)Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company's services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing. In addition, the company offers controlled environment storage services and diagnostic and genomic services and products. Sourcebio International Plc was founded in 1999 and is headquartered in Nottingham, the United Kingdom.Read More SBI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SBI Stock News HeadlinesJuly 4, 2023 | msn.comSBICAPS opens branch office in Abu Dhabi Global MarketJanuary 24, 2022 | finance.yahoo.comIs Sourcebio International Plc (LON:SBI) Popular Amongst Insiders?May 7, 2024 | DTI (Ad)Is Tesla going out of business?Goldman Sachs estimates that this new “Future Fuel” will unleash an $11.7 trillion wave of wealth over the coming decade. That’s 10 TIMES BIGGER than the electric vehicle market. January 18, 2022 | proactiveinvestors.comSourceBio International says full-year results will exceed expectationsDecember 30, 2021 | finance.yahoo.comSourcebio International Plc (SBI.L)December 14, 2021 | proactiveinvestors.comSourceBio will get boost from PCR testing upsurge as Omicron spreads, predicts brokerDecember 10, 2021 | finance.yahoo.comReturns On Capital Are A Standout For Sourcebio International (LON:SBI)October 26, 2021 | finance.yahoo.comEstimating The Intrinsic Value Of Sourcebio International Plc (LON:SBI)See More Headlines Receive SBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sourcebio International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolLON:SBI CUSIPN/A CIKN/A Webwww.sourcebioscience.com Phone44 11 5973 9012FaxN/AEmployees194Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio1,277.78 Forward P/E Ratio31.51 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio35.10 Current Ratio1.91 Quick Ratio1.78 Sales & Book Value Annual Sales£75.61 million Price / Sales1.13 Cash FlowGBX 21.32 per share Price / Cash Flow5.40 Book ValueGBX 61.90 per share Price / Book1.86Miscellaneous Outstanding Shares74,183,000Free FloatN/AMarket Cap£85.31 million OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Jay Charles LeCoque (Age 59)Exec. Chairman Mr. Anthony James Ratcliffe ACA (Age 58)BSc, MBA, CFO, Company Sec. & Exec. Director Mr. Russell WheatcroftChief Operating OfficerKey CompetitorsMedica GroupLON:MGPDiaceuticsLON:DXRXScancellLON:SCLPBATM Advanced CommunicationsLON:BVCMereo BioPharma Group plc (MPH.L)LON:MPHView All Competitors SBI Stock Analysis - Frequently Asked Questions How have SBI shares performed in 2024? Sourcebio International's stock was trading at GBX 115 at the start of the year. Since then, SBI stock has increased by 0.0% and is now trading at GBX 115. View the best growth stocks for 2024 here. How do I buy shares of Sourcebio International? Shares of SBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SBI) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sourcebio International Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.